» Articles » PMID: 33511284

Physician Awareness of Hepatitis C Virus Among Different Departments

Overview
Specialty Gastroenterology
Date 2021 Jan 29
PMID 33511284
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Aim Of The Study: To determine the anti-hepatitis C virus (HCV) positivity in our region and to evaluate physician awareness of HCV among different inpatient and outpatient departments in a tertiary reference center in Turkey.

Material And Methods: This retrospective study was conducted between January 2017 and January 2020. The patients tested for anti-HCV for any reason were enrolled from the data of all patients admitted to our hospital, which is the reference center of the region.

Results: A total of 121,492 anti-HCV assays were screened from the computerized database. Total number of patients with a positive anti-HCV result was 891 (0.81%). HCV RNA was positive in 147 (16.5%) of 891 patients and negative in 389 (43.7%) patients. Unfortunately HCV RNA was not tested in 355 (39.8%) patients. The percentages of the untested patients regarding the departments were 65.38% ( = 85/130) in medical inpatient clinics, 61.02% ( = 72/118) in surgical clinics, 16.67% ( = 88/528) medical outpatient departments, 96.8% ( = 91/94) in surgical outpatient departments, and 90.5% ( = 19/21) in the emergency department.

Conclusions: The prevalence of anti-HCV positivity was found to be 0.81% and was stable in Turkey. However, the level of physician awareness for HCV was unsatisfactory, and differed between departments. Because HCV is commonly asymptomatic, positive patients should not be overlooked and adequate treatment should be administered. Awareness of physicians should be increased to prevent delays in the diagnosis of hepatitis C and to reduce the number of untreated patients.

Citing Articles

Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis.

Turkoglu E, Parlak Z, Barut H Turk J Med Sci. 2023; 52(6):1984-1990.

PMID: 36945985 PMC: 10390156. DOI: 10.55730/1300-0144.5546.

References
1.
Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O . The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019; 5(1):60-66. PMC: 6362901. View

2.
Feng B, Zhang J, Wei L . Inadequate awareness of hepatitis C among nonspecialist physicians in China. Adv Med Educ Pract. 2013; 2:209-14. PMC: 3661259. DOI: 10.2147/AMEP.S23887. View

3.
Aydin G, Adaleti R, Boz E, Yucel F, Ozhan H, Aksaray S . [Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection]. Mikrobiyol Bul. 2020; 54(1):110-119. DOI: 10.5578/mb.68833. View

4.
Samuel S, Martinez A, Chen Y, Markatou M, Talal A . Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians. World J Hepatol. 2018; 10(2):319-328. PMC: 5838450. DOI: 10.4254/wjh.v10.i2.319. View

5.
Chan D, Sun H, Wong H, Lee S, Hung C . Sexually acquired hepatitis C virus infection: a review. Int J Infect Dis. 2016; 49:47-58. DOI: 10.1016/j.ijid.2016.05.030. View